Terms: = Head and neck cancer AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Staging
4 results:
1. Expression of cancer Stem Cell Biomarkers in Human head and neck Carcinomas: a Systematic Review.
Curtarelli RB; Gonçalves JM; Dos Santos LGP; Savi MG; Nör JE; Mezzomo LAM; Rodríguez Cordeiro MM
Stem Cell Rev Rep; 2018 Dec; 14(6):769-784. PubMed ID: 30076557
[TBL] [Abstract] [Full Text] [Related]
2. Loss of SRY-box2 (sox2) expression and its impact on survival of patients with oesophageal adenocarcinoma.
Ten Kate FJC; van Olphen SH; Bruno MJ; Wijnhoven BPL; van Lanschot JJB; Looijenga LHJ; Fitzgerald RC; Biermann K
Br J Surg; 2017 Sep; 104(10):1327-1337. PubMed ID: 28692180
[TBL] [Abstract] [Full Text] [Related]
3. Predicting the molecular role of MEIS1 in esophageal squamous cell carcinoma.
Rad A; Farshchian M; Forghanifard MM; Matin MM; Bahrami AR; Geerts D; A'rabi A; Memar B; Abbaszadegan MR
Tumour Biol; 2016 Feb; 37(2):1715-25. PubMed ID: 26314854
[TBL] [Abstract] [Full Text] [Related]
4. [Expression of sox2 protein and its clinical significance in laryngeal carcinoma].
Ye F; Huang G; Fu M; Ma Y; Kang H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Feb; 27(3):136-9. PubMed ID: 23700807
[TBL] [Abstract] [Full Text] [Related]
